More generally, our results emphasize the possibility that GATA3 plays a different prognostic role in various BC subtypes; this should be kept in mind for further studies in order to better clarify the additional prognostic information supplied by GATA3 for therapeutic decision-making, especially in luminal B BCs. Here, GATA3 is linked to breast cancer.